DCGI orders withdrawal of AstraZeneca’s Olaparib tablets for gBRCA mutation and advanced ovarian cancer due to potential adverse effects. The drug was approved in 2018 for adult patients with ovarian cancer and certain breast cancers.
India to withdraw AstraZeneca’s cancer drug
Posted on by satyavallam
You May Also Like
Habits that destroy the physical health of children
September 21, 2024
6 sacred symbols in Hinduism and what they mean
September 21, 2024
Why only walking might not be such a good idea
September 21, 2024
More From Author
Why only walking might not be such a good idea
September 21, 2024
6 sacred symbols in Hinduism and what they mean
September 21, 2024